Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty

NCT01206608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: SKY0402 + bupivacaine HCl
DRUG: Mid-dose SKY0402 + bupivacaine HCl

Sponsor

Pacira Pharmaceuticals, Inc